Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive approach. Supporters often highlight the possibility for substantial therapeutic benefits, principally in diseases where conventional treatments have proven ineffective. However, crucially important to assess the substantial financial expenditure associated with C